The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) will vote this afternoon on recommendations for the use of new r...

Merck is back home again in Rahway, New Jersey, at the site that it established 90 years ago as Merck Research Laboratories. After being headquartered for eight y...

Sanofi is jumping on the artificial intelligence boat with a new app and a pledge to become “the first pharma company powered by artificial intelligence at scale.” ...

Remember how bluebird bio retreated from Europe after failing to reach reimbursement deals for its gene therapies? Now, one team of analysts believes BioMarin’s hemo...

ProKidney is the latest company to join the bustling North Carolina manufacturing scene with a $25.5 million initial investment. The company has purchased 22 acre...

As the United States' opioid epidemic rages on, health officials are busy looking for ways to help with the response. Now, right on the heels of the FDA's approva...

In financial distress last May, AstraZeneca spinout Entasis Therapeutics sold out to holding company Innoviva for $113 million. A year later—to the day—Innoviva’s su...

Viatris Chairman Robert Coury has called the shots at Mylan and its successor Viatris for many years, but now he's getting ready to hang it up.  Later this y...

After the recent high-profile loss of exclusivity for AbbVie's megablockbuster immunology drug Humira, industry watchers' eyes moved to Johnson & Johnson's Stela...